| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Dopamine Receptor D1 Blocking Peptide for STJ500693 is synthetically produced from the 1-50 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
Drd1Uniprot ID=DRD1_RAT" |
| Immunogen Region: |
1-50 |
| Specificity: |
This blocking peptide is recommended for use in combination with Dopamine Receptor D1 antibody, STJ500693 |
| Immunogen: |
Synthetic peptide taken within amino acid region 1-50 on human D-1 dopamine receptor protein. |
| Tissue Specificity | Brain, in the striatum, the nucleus accumbens, and the olfactory tubercle. |
| Post Translational Modifications | N-glycosylated. |
| Function | Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase. |
| Peptide Name | D(1a Dopamine ReceptorDopamine D1 Receptor |
| Cellular Localisation | Cell MembraneMulti-Pass Membrane ProteinEndoplasmic Reticulum MembraneCell ProjectionDendriteDendritic SpineTransport From The Endoplasmic Reticulum To The Cell Surface Is Regulated By Interaction With Dnajc14 |
| Alternative Peptide Names | D(1a Dopamine Receptor proteinDopamine D1 Receptor proteinDrd1 proteinDrd1a protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
